Question 1

What are the potential side effects of Dupilumab compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I have questions or concerns during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) clinical trial (NCT04296864). Contact the study team or your healthcare provider for specific answers.

What this study is about